CATALOGO DEI PRODOTTI DELLA RICERCA

ROSSINI, Maurizio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.541
EU - Europa 14.714
AS - Asia 10.960
SA - Sud America 1.422
AF - Africa 154
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 16
Totale 43.840
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.352
GB - Regno Unito 5.185
SG - Singapore 4.545
CN - Cina 3.803
IT - Italia 1.923
HK - Hong Kong 1.289
DE - Germania 1.287
RU - Federazione Russa 1.287
BR - Brasile 1.234
FR - Francia 1.217
SE - Svezia 1.080
IE - Irlanda 1.043
FI - Finlandia 847
KR - Corea 300
UA - Ucraina 293
TR - Turchia 189
IN - India 182
VN - Vietnam 180
JP - Giappone 128
NL - Olanda 121
CA - Canada 100
BE - Belgio 73
AT - Austria 69
ES - Italia 58
AR - Argentina 54
IQ - Iraq 49
PL - Polonia 49
BD - Bangladesh 47
MX - Messico 47
TG - Togo 42
RO - Romania 40
ID - Indonesia 38
EC - Ecuador 35
ZA - Sudafrica 34
IR - Iran 33
UZ - Uzbekistan 29
AU - Australia 27
VE - Venezuela 26
CL - Cile 23
CO - Colombia 21
NP - Nepal 19
EG - Egitto 17
MA - Marocco 16
CH - Svizzera 15
CZ - Repubblica Ceca 14
SA - Arabia Saudita 14
SK - Slovacchia (Repubblica Slovacca) 13
GR - Grecia 12
PK - Pakistan 12
PT - Portogallo 12
IL - Israele 11
BG - Bulgaria 10
JO - Giordania 10
HR - Croazia 9
PY - Paraguay 9
AZ - Azerbaigian 8
EU - Europa 8
JM - Giamaica 8
KE - Kenya 8
BO - Bolivia 7
LT - Lituania 7
PE - Perù 7
A2 - ???statistics.table.value.countryCode.A2??? 6
AE - Emirati Arabi Uniti 6
DZ - Algeria 6
HN - Honduras 6
KG - Kirghizistan 6
TN - Tunisia 6
AL - Albania 5
DK - Danimarca 5
KW - Kuwait 5
OM - Oman 5
PH - Filippine 5
QA - Qatar 5
TH - Thailandia 5
CR - Costa Rica 4
DO - Repubblica Dominicana 4
EE - Estonia 4
IS - Islanda 4
LB - Libano 4
LK - Sri Lanka 4
LV - Lettonia 4
MK - Macedonia 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
SI - Slovenia 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
AM - Armenia 3
BH - Bahrain 3
BW - Botswana 3
BY - Bielorussia 3
GH - Ghana 3
HU - Ungheria 3
MN - Mongolia 3
MY - Malesia 3
NI - Nicaragua 3
PS - Palestinian Territory 3
RS - Serbia 3
SN - Senegal 3
Totale 43.784
Salva come PNG Salva come JPEG
Città #
Southend 4.776
Jacksonville 2.237
Chandler 2.205
Singapore 2.117
Dallas 1.808
Hong Kong 1.271
Woodbridge 1.234
Dublin 1.027
Ann Arbor 959
Ashburn 821
Houston 674
Beijing 581
Lawrence 447
Princeton 447
Wilmington 423
Jinan 329
Nanjing 295
New York 284
Shenyang 280
Verona 247
Redmond 238
Bologna 207
Los Angeles 201
Helsinki 198
Milan 185
Sindelfingen 178
Hebei 175
Munich 167
The Dalles 150
Tianjin 147
Changsha 134
Columbus 129
Ningbo 113
Tokyo 113
Haikou 109
Zhengzhou 109
Boardman 107
Nanchang 107
São Paulo 98
Hangzhou 92
Jiaxing 88
Taizhou 86
Buffalo 82
Seattle 79
Rome 78
Guangzhou 75
Santa Clara 75
Redwood City 72
Taiyuan 68
Brussels 65
Norwalk 65
San Francisco 63
Turku 58
Washington 57
Moscow 52
Falls Church 51
Fairfield 48
Ho Chi Minh City 47
Hyderabad 47
Chicago 45
Dearborn 42
Fuzhou 42
Lanzhou 42
Lomé 42
Vienna 42
Dong Ket 41
Orani 40
Belo Horizonte 37
Brooklyn 37
Toronto 36
Warsaw 36
Rio de Janeiro 35
Brasília 31
London 31
Düsseldorf 30
Jakarta 30
Nuremberg 30
Amsterdam 29
Seoul 28
Boston 27
Tashkent 27
Dongguan 26
Frankfurt am Main 26
Groningen 26
Atlanta 24
Cagliari 24
Detroit 24
Council Bluffs 22
Lancaster 22
Redondo Beach 22
Hanoi 21
Johannesburg 21
Phoenix 21
Lappeenranta 20
Mexico City 20
Sanayi 20
Campinas 19
Paris 19
Curitiba 18
Nürnberg 18
Totale 27.868
Salva come PNG Salva come JPEG
Nome #
Fibromialgia. Razionale e risultati del trattamento con L-Acetilcarnitina. 394
Epidemiology and Economic Burden of Osteoporosis in Italy 357
Teriparatide and denosumab combination therapy and skeletal metabolism 266
Epidemiology of mastocytosis in adults based on a multidisciplinary diagnostic approach. 258
Real-World Effectiveness of Bimekizumab in Predominantly Difficult-to-Treat Patients with Psoriatic Arthritis Followed in a Combined Dermatology-Rheumatology Clinic: A 24-Week Multicenter Study 244
La correzione dell’ipovitaminosi D nel lungo termine: confronto tra diverse modalità di somministrazione di vitamina D nella pratica clinica. 200
Artrite Reumatoide e Metabolismo Minerale 197
Trattamento dell'osteoporosi cortisonica con Nandrolone Decanoato 185
[The long term correction of vitamin D deficiency: comparison between different treatments with vitamin D in clinical practice.]. 183
Acute Phase Response After Zoledronic Acid is Associated with Long-Term Effects on White Blood Cells. 180
Association of CTR and COLIA1 alleles with BMD values in peri and postmenopausal women 175
CD14(++) CD16(-) monocytes are the main source of 11β-HSD type 1 after IL-4 stimulation 175
A case of adult chronic recurrent multifocal osteomyelitis successfully treated with neridronate 174
The effects of menopause and estrogen replacement therapy on the renal handling of calcium 169
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 168
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 168
[Diphosphonates: and alternative to estrogen therapy in postmenopausal osteoporosis. Experience with alendronate] 167
The genetic background of osteoporosis in cystic fibrosis: association analysis with polymorphic markers in four candidate genes 159
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 155
Clonal mast cell disorders limited to bone marrow: not a negligible disease. 155
[Therapeutic strategies in osteoporosis: whom and when to treat] 152
Incidenza di ipovitaminosi D nel Nord Italia 151
Age-related bone loss in postmenopausal women 151
Bone mineral density and bone turnover in premenopausal women with rheumatoid arthritis 151
Value of flow cytometry in the diagnosis of indolent systemic mastocytosis. 149
Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis 148
Bone metabolism in patients with anorexia nervosa and amenorrhoea 146
Longitudinal Evaluation of Bone Mineral Density and Bone Metabolism Markers in Patients with Indolent Systemic Mastocytosis Without Osteoporosis 145
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 142
Anti-CCP antibodies and bone 142
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 141
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 140
Prednisone compared to methysprednisolone in the polymyalgia rheumatica treatment 139
Clinical utility of a wheat-germ precipitation assay for determination of bone alkaline phosphatase concentrations in patients with different metabolic bone diseases 139
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 138
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. 137
Rapporti tra sistema immune e metabolismo osseo 137
[Risk factors for hip fracture in elderly persons]. 137
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 137
DXA bone mineral density in males: retrospective study in real life. 135
Prevalence and incidence of rheumatoid arthritis in Italy. 135
New strategies for the prevention and treatment of systemic and local bone loss; from pathophysiology to clinical application 135
Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I. 134
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 134
Concentric left ventricular remodelling is associated with subclinical systolic dysfunction in patients with psoriatic arthritis 134
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 132
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 131
Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone 130
Bisphosphonates vs infliximab in ankylosing spondylitis treatment. 130
Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial 129
[Study of vitamin D status of rheumatoid arthritis patients. Rationale and design of a cross-sectional study by the osteoporosis and metabolic bone diseases study group of the Italian Society of Rheumatology (SIR)]. 127
Guidelines for the diagnosis, prevention and management of osteoporosis 127
Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes 127
Bone involvement in patient with clonal mast cell disorders 125
Bone involvement and osteoporosis in mastocytosis. 125
Osteoporosis treatment: why ibandronic acid? 124
Clinical profile and outcome of patients with rheumatoid arthritis and abnormally high aortic stiffness 124
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series 123
Vitamin D levels in patients with psoriasis with or without arthritis 122
A case of mandible Paget’s disease of the bone treated with intravenous neridronate 122
Sclerostin and DKK1 in postmenopausal osteoporosis treated with Denosumab. 122
The renal handling of calcium: influence of parathyroid hormone secretion 121
Prevalence of osteoporosis in patients affected by mastocytosis 120
Could γ\δ T-cells explain zoledronic acid adverse events? 120
Dose-dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers 119
Safety issues and adverse reactions with osteoporosis management 119
Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis 119
Rituximab increases peripheral natural killer cells in patients with rheumatoid arthritis 119
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 118
Effects of two oral doses of alendronate in the treatment of Paget's disease of bone 117
Incidenza di ipovitaminosi D nel Nord Italia 117
Osteoporosi: progressi nella diagnosi e nel trattamento 117
Osteopetrosi 117
Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels 117
Suboptimal methotrexate use in rheumatoid arthritis patients in Italy: the MARI study 117
18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity 117
Challenge of diagnosing ANCA-associated vasculitis during COVID-19 pandemic: a missed 'window of opportunity' 117
Anabolic steroids in corticosteroid-induced osteoporosis 116
Allergy and the bone: unexpected relationships 116
Systemic mastocytosis: a muldisciplinary approach (Review) [Lamastocitosi sistemica: Un approccio multidiscliplinare] 116
Regulation of calcium-parathyroid hormone feedback in primary hyperparathyroidism: effects of bisphosphonate treatment 115
The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate 115
Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis 115
Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis. 115
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 115
Gender differences in clinical features and quality of life of patients with axial spondyloarthritis and psoriatic arthritis 115
Bone turnover markers in patients with osteogenesis imperfecta 114
Intermittent etidronate partially prevents bone loss in hirsute hyperandrogenic women treated with GnRH Agonist. 114
Bone turnover markers in patients with osteogenesis imperfecta. 114
Prevalence and factors related to left ventricular systolic dysfunction in asymptomatic patients with rheumatoid arthritis. A prospective tissue Doppler echocardiography study 114
Denosumab, cortical bone and bone erosions in rheumatoid arthritis 114
Drug-induced osteonecrosis of the jaw: the state of the art 114
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 114
Sclerostin and DKK1 in primary hyperparathyroidism. 113
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 113
Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis. 112
Improvements in the management of rheumatic patients from vertebral imagee obtained through dual-energy X-ray absorptiometry. 112
Vitamin D affects insulin sensitivity and β-cell function in obese non-diabetic youths 112
Effects of denosumab on peripheral lymphocyte subpopulations 112
Bone Disease in Mastocytosis 111
Totale 14.190
Salva come PNG Salva come JPEG
Categoria #
all - tutte 171.481
article - articoli 164.041
book - libri 0
conference - conferenze 2.451
curatela - curatele 0
other - altro 453
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.536
Totale 342.962
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.722 0 0 112 434 496 425 82 242 306 27 440 158
2021/20223.269 238 807 49 158 155 128 61 185 278 97 305 808
2022/20236.835 560 555 703 1.180 607 1.652 86 384 732 75 226 75
2023/20243.514 179 270 330 418 403 534 180 274 58 128 494 246
2024/20259.554 564 679 406 1.475 472 257 444 469 1.414 810 701 1.863
2025/20264.831 1.946 1.344 1.541 0 0 0 0 0 0 0 0 0
Totale 44.607